biolq: the income statement

MyFinsight

BIOLASE, INC (BIOLQ)

For the quarter ending 2024-09-30, BIOLQ made $10,850K in revenue. -$1,299K in net income. Net profit margin of -11.97%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2024-09-30
Net revenue	10,850
Cost of revenue	6,468
Gross profit	4,382
Selling and marketing expense, total	2,877
Research and development expense, total	917
General and administrative expense, total	1,283
Operating expenses	5,077
Operating income (loss)	-695
Other income (loss), net	-47
Interest expense, net	-605
Gain (loss) on foreign currency transactions	-69
Nonoperating income (expense)	-721
Income (loss) from continuing operations before income taxes, noncontrolling interest	-1,416
Income tax (benefit)	12
Net loss	-1,428
Foreign currency translation adjustments	129
Comprehensive income (loss), net of tax, attributable to parent	-1,299

Basic eps	-0.04
Diluted eps	-0.04
Basic average shares	36,083,000
Diluted average shares	36,083,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS)